dr. anil anti - ageing limited Company Information
Company Number
09801697
Website
dranil.co.ukRegistered Address
pine trees seven hills road, cobham, KT11 1ER
Industry
General medical practice activities
Telephone
02037976460
Next Accounts Due
June 2025
Group Structure
View All
Directors
Anil Budh-Raja9 Years
Shareholders
anil budh-raja 84.4%
lady yomara rodriguez cardenas 15.6%
dr. anil anti - ageing limited Estimated Valuation
Pomanda estimates the enterprise value of DR. ANIL ANTI - AGEING LIMITED at £400.1k based on a Turnover of £983.2k and 0.41x industry multiple (adjusted for size and gross margin).
dr. anil anti - ageing limited Estimated Valuation
Pomanda estimates the enterprise value of DR. ANIL ANTI - AGEING LIMITED at £178.8k based on an EBITDA of £54.1k and a 3.31x industry multiple (adjusted for size and gross margin).
dr. anil anti - ageing limited Estimated Valuation
Pomanda estimates the enterprise value of DR. ANIL ANTI - AGEING LIMITED at £1m based on Net Assets of £367.1k and 2.84x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Dr. Anil Anti - Ageing Limited Overview
Dr. Anil Anti - Ageing Limited is a live company located in cobham, KT11 1ER with a Companies House number of 09801697. It operates in the general medical practice activities sector, SIC Code 86210. Founded in September 2015, it's largest shareholder is anil budh-raja with a 84.4% stake. Dr. Anil Anti - Ageing Limited is a young, small sized company, Pomanda has estimated its turnover at £983.2k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Dr. Anil Anti - Ageing Limited Health Check
Pomanda's financial health check has awarded Dr. Anil Anti - Ageing Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
5 Weak
Size
annual sales of £983.2k, make it smaller than the average company (£1.8m)
- Dr. Anil Anti - Ageing Limited
£1.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 14%, show it is growing at a faster rate (6.3%)
- Dr. Anil Anti - Ageing Limited
6.3% - Industry AVG
Production
with a gross margin of 21.2%, this company has a higher cost of product (36.7%)
- Dr. Anil Anti - Ageing Limited
36.7% - Industry AVG
Profitability
an operating margin of 5.5% make it as profitable than the average company (4.8%)
- Dr. Anil Anti - Ageing Limited
4.8% - Industry AVG
Employees
with 1 employees, this is below the industry average (19)
1 - Dr. Anil Anti - Ageing Limited
19 - Industry AVG
Pay Structure
on an average salary of £31.3k, the company has an equivalent pay structure (£31.3k)
- Dr. Anil Anti - Ageing Limited
£31.3k - Industry AVG
Efficiency
resulting in sales per employee of £983.2k, this is more efficient (£79.8k)
- Dr. Anil Anti - Ageing Limited
£79.8k - Industry AVG
Debtor Days
it gets paid by customers after 146 days, this is later than average (37 days)
- Dr. Anil Anti - Ageing Limited
37 days - Industry AVG
Creditor Days
its suppliers are paid after 18 days, this is quicker than average (25 days)
- Dr. Anil Anti - Ageing Limited
25 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Dr. Anil Anti - Ageing Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Dr. Anil Anti - Ageing Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 13.3%, this is a lower level of debt than the average (60.2%)
13.3% - Dr. Anil Anti - Ageing Limited
60.2% - Industry AVG
DR. ANIL ANTI - AGEING LIMITED financials
Dr. Anil Anti - Ageing Limited's latest turnover from September 2023 is estimated at £983.2 thousand and the company has net assets of £367.1 thousand. According to their latest financial statements, Dr. Anil Anti - Ageing Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | |
---|---|---|---|---|---|---|---|---|
Turnover | ||||||||
Other Income Or Grants | ||||||||
Cost Of Sales | ||||||||
Gross Profit | ||||||||
Admin Expenses | ||||||||
Operating Profit | ||||||||
Interest Payable | ||||||||
Interest Receivable | ||||||||
Pre-Tax Profit | ||||||||
Tax | ||||||||
Profit After Tax | ||||||||
Dividends Paid | ||||||||
Retained Profit | ||||||||
Employee Costs | ||||||||
Number Of Employees | 1 | 1 | 1 | 1 | 1 | |||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | |
---|---|---|---|---|---|---|---|---|
Tangible Assets | 28,032 | 33,222 | 35,526 | 44,369 | 16,212 | 3,954 | 949 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 28,032 | 33,222 | 35,526 | 44,369 | 16,212 | 3,954 | 949 | 0 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 395,241 | 365,206 | 341,104 | 294,050 | 180,576 | 122,915 | 70,899 | 1,613 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 322 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 395,241 | 365,206 | 341,104 | 294,050 | 180,576 | 122,915 | 70,899 | 1,935 |
total assets | 423,273 | 398,428 | 376,630 | 338,419 | 196,788 | 126,869 | 71,848 | 1,935 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 38,644 | 44,507 | 96,655 | 96,563 | 77,652 | 67,795 | 35,854 | 993 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 38,644 | 44,507 | 96,655 | 96,563 | 77,652 | 67,795 | 35,854 | 993 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 17,565 | 27,433 | 37,000 | 50,000 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 17,565 | 27,433 | 37,000 | 50,000 | 0 | 0 | 0 | 0 |
total liabilities | 56,209 | 71,940 | 133,655 | 146,563 | 77,652 | 67,795 | 35,854 | 993 |
net assets | 367,064 | 326,488 | 242,975 | 191,856 | 119,136 | 59,074 | 35,994 | 942 |
total shareholders funds | 367,064 | 326,488 | 242,975 | 191,856 | 119,136 | 59,074 | 35,994 | 942 |
Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | |
---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||
Operating Profit | ||||||||
Depreciation | 0 | |||||||
Amortisation | 0 | |||||||
Tax | ||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 30,035 | 24,102 | 47,054 | 113,474 | 57,661 | 52,016 | 69,286 | 1,613 |
Creditors | -5,863 | -52,148 | 92 | 18,911 | 9,857 | 31,941 | 34,861 | 993 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | ||||||||
Investing Activities | ||||||||
capital expenditure | ||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||
Financing Activities | ||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | -9,868 | -9,567 | -13,000 | 50,000 | 0 | 0 | 0 | 0 |
share issue | ||||||||
interest | ||||||||
cash flow from financing | ||||||||
cash and cash equivalents | ||||||||
cash | 0 | 0 | 0 | 0 | 0 | 0 | -322 | 322 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 0 | 0 | 0 | 0 | 0 | 0 | -322 | 322 |
dr. anil anti - ageing limited Credit Report and Business Information
Dr. Anil Anti - Ageing Limited Competitor Analysis
Perform a competitor analysis for dr. anil anti - ageing limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in KT11 area or any other competitors across 12 key performance metrics.
dr. anil anti - ageing limited Ownership
DR. ANIL ANTI - AGEING LIMITED group structure
Dr. Anil Anti - Ageing Limited has no subsidiary companies.
Ultimate parent company
DR. ANIL ANTI - AGEING LIMITED
09801697
dr. anil anti - ageing limited directors
Dr. Anil Anti - Ageing Limited currently has 1 director, Dr Anil Budh-Raja serving since Sep 2015.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Anil Budh-Raja | England | 50 years | Sep 2015 | - | Director |
P&L
September 2023turnover
983.2k
+36%
operating profit
54.1k
0%
gross margin
21.3%
+2.33%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
367.1k
+0.12%
total assets
423.3k
+0.06%
cash
0
0%
net assets
Total assets minus all liabilities
dr. anil anti - ageing limited company details
company number
09801697
Type
Private limited with Share Capital
industry
86210 - General medical practice activities
incorporation date
September 2015
age
9
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
September 2023
previous names
N/A
accountant
-
auditor
-
address
pine trees seven hills road, cobham, KT11 1ER
Bank
-
Legal Advisor
-
dr. anil anti - ageing limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to dr. anil anti - ageing limited.
dr. anil anti - ageing limited Companies House Filings - See Documents
date | description | view/download |
---|